EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Novel Antimicrobial-Active Compounds and Their Analogues by In Silico Small Chemical Screening Targeting Staphylococcus aureus MurB

Saya Okubo, Shoki Hirose, Shunsuke Aoki iD

Molecules · 2025

DOI: 10.3390/molecules30071477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Saya Okubo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Staphylococcus aureus, Drug Discovery, Small Molecule Libraries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyushu Institute of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus is a serious problem in healthcare due to its lethal severe infections and resistance to most antimicrobial agents. The number of new approved antimicrobial agents is declining, and combined with the spread of drug-resistant bacteria, it is predicted that effective antimicrobial agents against multidrug-resistant bacteria will be exhausted. We conducted in silico and in vitro discovery of novel antimicrobial small molecules targeting the SaMurB enzyme involved in cell wall synthesis in Staphylococcus aureus (S. aureus). We performed hierarchical structure-based drug screenings to identify compounds and their analogues using a library of approximately 1.3 million compound structures. In vitro experiments with Staphylococcus epidermidis (S. epidermidis) identified three compounds (SH5, SHa6, and SHa13) that exhibit antibacterial activity. These three compounds do not have toxicity against human-derived cells. SHa13 exhibited remarkable activity (IC50 value =1.64 ± 0.01 µM). The active compound was predicted to bind to the active site of SaMurB by forming a hydrogen bond with Arg188 in both R and S bodies. These data provide a starting point for the development of novel cell wall synthesis inhibitors as antimicrobial agents targeting SaMurB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStaphylococcus aureusDrug DiscoverySmall Molecule LibrariesBacterial ProteinsHumansMicrobial Sensitivity TestsComputer SimulationDrug Evaluation, PreclinicalStaphylococcus epidermidisMolecular Docking SimulationMethicillin-Resistant Staphylococcus aureus

Stichwörter der Autor:innen

MD simulationMurBSBDSStaphylococcusenantiomerin vitro experimentvirtual screening

Substanzen

Anti-Bacterial AgentsSmall Molecule LibrariesBacterial Proteins

Autor:innen und Institutionen

  • Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.

ORCID-Profile: Shunsuke Aoki

Förderung

  • Kyushu Institute of Technology

Zitieren

APA

Okubo, S., Hirose, S., & Aoki, S. (2025). Discovery of Novel Antimicrobial-Active Compounds and Their Analogues by In Silico Small Chemical Screening Targeting Staphylococcus aureus MurB. Molecules. https://doi.org/10.3390/molecules30071477

Vancouver

Okubo S, Hirose S, Aoki S. Discovery of Novel Antimicrobial-Active Compounds and Their Analogues by In Silico Small Chemical Screening Targeting Staphylococcus aureus MurB. Molecules. 2025. doi:10.3390/molecules30071477

BibTeX
@article{Okubo2025,
  author = {Okubo, Saya and Hirose, Shoki and Aoki, Shunsuke},
  title = {Discovery of Novel Antimicrobial-Active Compounds and Their Analogues by In Silico Small Chemical Screening Targeting Staphylococcus aureus MurB},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30071477}
}
Kostenlos starten →